FDA panel narrowly backs Merck's at-home COVID-19 pill

FDA panel narrowly backs Merck's at-home COVID-19 pill

on Also in , , ,
A panel of expert advisers to the U.S. Food and Drug Administration on Tuesday narrowly voted to recommend the agency authorize Merck & Co's antiviral pill to treat COVID-19.

Share:

Previous
Next

Comentarios

Publicar un comentario

Leave a comment. Thanks!

Comentarios de Facebook

Suscribirse a: Enviar comentarios (Atom)